15 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the 15 top performing European stocks so far in 2024.
Source: insidermonkey.com
📰 Commodore Capital News
Page 2 - Commodore Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Commodore Capital. Real-time updates on events, politics, business and more.
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
Pro-forma cash, cash equivalents and marketable securities expected to fund the Company into 2027 and through clinical readouts from ongoing SUMMIT, PEAK and APEX registration-directed trials
United States Christi Waarich Andrew Robbins Exchange Commission Cogent Biosciences Inc American Academy Of Asthma
Source: eagletribune.com
Vaxcyte (NASDAQ:PCVX) Reaches New 12-Month High at $66.48
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $66.48 and last traded at $66.41, with a volume of 180384 shares traded. The stock had previously closed at $64.31. Analyst Ratings Changes A number of analysts recently commented on […]
United States Mikhail Eydelman Cantor Fitzgerald Vaxcyte Inc Groupa Streptococcus Fred Alger Management
Source: dailypolitical.com
Baystreet.ca - ORIC Hails Private Placement
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) saw its shares shoot up Monday. The San Francisco-based clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that it has agreed to ...
Frazier Life Sciences Oric Pharmaceuticals Inc San Francisco Based Viking Global Investors Commodore Capital Venrock Healthcare Capital Partners
Source: baystreet.ca
ORIC Pharmaceuticals Announces $125 Mln Private Placement, Stock Up In Pre-market
(RTTNews) - ORIC Pharmaceuticals, Inc. (ORIC), a clinical-stage oncology company, Monday announced that it has agreed to sell around 12.5 million ...
Pharmaceuticals Inc Frazier Life Sciences Viking Global Investors Commodore Capital Venrock Healthcare Capital Partners
Source: businessinsider.com
Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week
Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...
Eddie Sullivan Biotherapeutics Inc Commodore Capital Institutional Investors Ndividual Investors Ownership Structure
Source: yahoo.com
11 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]
Source: yahoo.com
11 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.
Source: insidermonkey.com
Latest biotech news: fundraises, deals, clinical trials
What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
Source: labiotech.eu
Commodore Capital LP Has $52.26 Million Holdings in Ambrx Biopharma Inc. (NYSE:AMAM)
Commodore Capital LP lowered its position in shares of Ambrx Biopharma Inc. (NYSE:AMAM – Free Report) by 33.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,175,000 shares of the company’s stock after selling 1,628,447 shares during the period. […]
Ambrx Biopharma Sonja Nelson Cantor Fitzgerald Royal Bank Ambrx Biopharma Inc B Riley Wealth Advisors Inc
Source: wkrb13.com